Table 1.

Baseline characteristics

Variable	METS-R	RYGB-R	P value	METS-D	RYGB-D
Weight (kg)	119	119	0.99	118	114
BMI (kg/m²)	37.4	36.0	0.55	33.8	31.4
Fasting plasma glucose (mmol/L)	5.48	5.03	0.17
Fasting insulin (pmol/L)	99.4	95.1	0.85	116	46
HOMA1-IR (mean)	3.14	2.89	0.65
Rd (µmol/kg/min)	40.6	33.9	0.37	31.8	50.5
EGP suppression (%)	77.4	75.9	0.82	71.5	85.7
Lipolysis suppression (%)	67	66	0.86	64	74
Excreted Sitzmark (n)*	53	40	0.27	58	51
REE (kcal/kg)	17.5	17.4	0.84	18.5	17.3
Total cholesterol (mmol/L)	5.2	4.9	0.45	6.1	4.0
HDL (mmol/L)	1.18	1.06	0.17	1.08	1.60
Dietary intake
Calories (kcal/day)	2033	1903	0.57	2073	2226
Fat (g/day)	73.0	67.9	0.64	66.3	82.7
Saturated fat (g/day)	29.6	25.1	0.28	23.6	30.0
Protein (g/day)	84.11	86.4	0.80	138.4	132.0
Carbohydrates (g/day)	214.6	206.2	0.80	139.1	193.4
Fibre (g/day)	16.71	19.0	0.22	17.3	18.9
Alcohol (units/week)	8	5	0.50	6	11

Means are reported unless stated otherwise.

*Median instead of mean reported.

BMI, body mass index; EGP, endogenous glucose production; FMT, faecal microbiota transplantation; HDL, high-density lipoprotein; HOMA1-IR, homeostatic model assessment-insulin resistance; METS-R, recipients with metabolic syndrome who received FMT from donors with metabolic syndrome; METS-D, metabolic syndrome donors; Rd, rate of glucose disappearance; REE, resting energy expenditure; RYGB-D, Roux-en-Y gastric bypass donor; RYGB-R, recipients with metabolic syndrome who received FMT from post-Roux-en-Y gastric bypass donors.